Top Ten Common Prejudices About Polyethylene Naphthalate Market.

Sterile lancets are single-use disposable needles that puncture the skin to obtain blood samples.Sterile Lancets Market can be used as a standalone safety lancet or in conjunction with a lancing device that holds the lancet in place while pricking the skin. Sterile lancets can also be used to perform allergy testing on the skin.
The most typical application of Sterile Lancets Market in diabetes patients is to check blood glucose levels, but they can also be used to collect blood samples for other diagnostic testing. It protects against contamination and unintentional accidents.
One of the primary factors driving the Sterile Lancets Market is the rising prevalence of diabetes. According to the International Diabetes Federation's (IDF) Diabetes Atlas 2017, there were over 425 million diabetic patients globally at the end of 2017, with that number predicted to rise to around 629 million by 2045. Furthermore, about 40% of persons with diabetes are still undiagnosed, particularly in Asia Pacific, the Middle East, and parts of North Africa. These patients would require insulin therapy, driving up demand for sterile lancets and propelling the sterile lancets market forward.
Diabetes is one of the top three causes of death from noncommunicable diseases, according to a 2012 factsheet published by the World Health Organization (WHO). Obesity is caused by a change in lifestyle that includes a more sedentary schedule and a high calorie intake. Another factor boosting the Sterile Lancets Market is the growing elderly population, as older people often require continuous glucose monitoring due to high rates of uncontrolled diabetes. According to IDF estimates from 2017, there were over 98 million diabetes people over the age of 65 in the world in 2017, with that number predicted to rise to around 191 million by 2045.
Globally strict criteria for safe injection methods to collect blood are projected to drive demand for sterile lancets, as they eliminate the risk of bloodborne pathogen contamination. According to a report released by the World Health Organization (WHO) in 2014, around 1.7 million persons were infected with the hepatitis B virus, 315,000 with the hepatitis C virus, and 33,800 with HIV as a result of improper injection.
The Sterile Lancets Market is also predicted to increase due to novel products offered by leading players. For example, the BD Microtainer Contact-Activated Lancet from Becton, Dickinson and Company enables for faster blood sample and covers a tiny area at the contact point, improving visualisation of the targeted puncture site. It is activated only when pressure is applied to the lancet.
The global market for sterile lancets is dominated by North America. According to the International Diabetes Federation (IDF), the United States has the greatest prevalence of diabetes (13 percent of the population). The biggest amount of money spent on diabetes is spent in North America. According to the IDF report 2017, the United States spends over US$ 377 billion annually on diabetes disease treatment, accounting for around 52 percent of total diabetes expenditure worldwide.
Furthermore, diabetes affects 30.3 million people in the United States (9.4% of the population), with 23.1 million diagnosed and 7.2 million undiagnosed.
Due to the greatest number of diabetes patients in the area, Asia Pacific is predicted to have the fastest CAGR and provide attractive prospects for the sterile lancet market throughout the forecast period. According to IDF data, China (114.4 million people) and India (72.9 million people) are among the top three economies with the highest diabetes prevalence.
Comments
Post a Comment